NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Axcelead Drug Discovery Partners, Inc.

Axcelead Drug Discovery Partners, Inc.

Private
FujisawaHealthcare & Life Scienceshttps://axcelead-us.com/

Last Round

Buyout/LBO

Apr 1, 2019

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Axcelead Drug Discovery Partners, Inc. is a pharmaceutical research company that provides integrated drug discovery and non-clinical research solutions.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

contract research organizationCROdrug discoverypreclinical researchdrug developmenthigh-throughput screeningHTSpharmacology servicesDMPKsafety assessmentbioinformaticsAI drug discoveryin silico discoverylead optimizationbiotech services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Axcelead Drug Discovery Partners, Inc. Comparables

Compare Axcelead Drug Discovery Partners, Inc. with similar companies based on industry and business-model similarity.

Axcelead Drug Discovery Partners, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sygnature Discovery
83%
Evotec
80%
Charles River Laboratories
76%

Axcelead Drug Discovery Partners, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Buyout/LBOApr 1, 2019

Axcelead Drug Discovery Partners, Inc. Investors

Notable investors and investment history

Axcelead Drug Discovery Partners, Inc. investors
InvestorRounds
WHIZ Partners, Inc.Buyout/LBO

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 21, 2026

    Monthly visitors grew 308% MoM.

  • Jul 6, 2025

    Monthly visitors increased 68% MoM.

Axcelead Drug Discovery Partners, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Axcelead Drug Discovery Partners, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Axcelead Drug Discovery Partners, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersFujisawa
Employee Range106
Year Founded2017
Last FundingApr 1, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.